Taiwan Healthcare Industry Alliance Adds New Team! The chairman of Meridigen Biotech, Mr. John Hsuan, and Mr. I-Shou Lin of E-United Group, announced cooperation Stem cell research on 27th January, 2015. Yogi Hsuan, the president of Meridigen has said that the amount of up to ten billion dollars investment plan, expected there will be two drugs enter human clinical stem cells trial in two years, also, build up Taiwan’s largest stem cell banking.

This will rewrite as the hugest investment plan in biomedical industry, two parties signed up Memorandum of Understanding on 27th January, declared Meridigen Biotech has officially stationed in E-Da cancer hospital, and set up core laboratory, to create the largest stem cell banking in Taiwan, jointly established in line with GMP regulations platform and clinical Center.

Soon, Meridigen, E-United Group, and NCTU will co-sign a Memorandum of Understanding.

Published in Commercial Times, Feb. 26 2014